Explore beyond tenders & contracts Start 14 days free trial

Find public sector tenders

Search and find UK govt public sector tenders - full contract/frameworks/DPS/Prior information notice

Search for tenders by ...

Awarded
Published : 3rd Mar 2026

Descriptions
Oncotype DX is a validated genomic assay recommended by NICE (DG34) for guiding chemotherapy decisions in specific cohorts of early breast cancer. It provides a Recurrence Score that stratifies patients into groups where chemotherapy is beneficial ve ....
Awarded
Descriptions
Call off contract from framework.
Awarded
Descriptions
Provision of Oncotype DX Breast Recurrence Score testing which addresses the issue of overtreatment with chemotherapy, particularly for patients with lymph nod-positive breast cancer.
Awarded
Descriptions
Breast Cancer Recurrence Score Test contract ref PTH-22-21-11621Contract extension taken 1st July 2025
Awarded
Descriptions
Oncotype DX Breast Recurrence Score contract. This a direct award via National Framework agreement Laboratory Diagnostics, Point of Care Testing & Pathology Managed Service. URN CPQ 56677 LAB 25
Awarded
Descriptions
The Oncotype DX Breast Recurrence Score.
Awarded
Descriptions
The service is available to patients aged 18 and over with a registered GP in the SNEE area. This service sits within the stroke and neuro rehabilitation suite of services to help support those who are suffering the affects of a stroke. Comprehensive ....
Awarded
Descriptions
This notice is being posted to inform of an award of contract to Exact Sciences UK Ltd for the supply of Oncotype DX Breast Recurrence Score Tests . The award is made via the NHS Supply Chain Framework Agreement 2023/s 000-028831.
Awarded
Descriptions
Call off contract from framework.
Awarded
Descriptions
Oncotype DX Breast Recurrence Score Test